Chemed Net Acquisitions/Divestitures 2010-2025 | CHE

Chemed annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
  • Chemed net acquisitions/divestitures for the quarter ending March 31, 2025 were $0.000B, a 96.92% decline year-over-year.
  • Chemed net acquisitions/divestitures for the twelve months ending March 31, 2025 were $-0.287B, a 1742.65% increase year-over-year.
  • Chemed annual net acquisitions/divestitures for 2024 were $-0.097B, a 2338.66% increase from 2023.
  • Chemed annual net acquisitions/divestitures for 2023 were $-0.004B, a 13.18% increase from 2022.
  • Chemed annual net acquisitions/divestitures for 2022 were $-0.004B, a 0% decline from 2021.
Chemed Annual Net Acquisitions/Divestitures
(Millions of US $)
2024 $-97
2023 $-4
2022 $-4
2021 $N/A
2020 $-4
2019 $-138
2018 $-53
2017 $-5
2016 $N/A
2015 $-7
2014 $0
2013 $-2
2012 $-6
2011 $-4
2010 $-9
2009 $-2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.282B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.694B 19.41
Encompass Health (EHC) United States $12.072B 25.59
DaVita (DVA) United States $10.842B 15.24
Elanco Animal Health (ELAN) United States $6.427B 13.77
Option Care Health (OPCH) United States $5.320B 23.72
RadNet (RDNT) United States $4.521B 286.95
Amedisys (AMED) United States $3.076B 20.69
LifeStance Health (LFST) United States $2.252B 0.00
Addus HomeCare (ADUS) United States $2.022B 22.20
Astrana Health (ASTH) United States $1.517B 37.58
U.S Physical Therapy (USPH) United States $1.189B 30.69
Aveanna Healthcare Holdings (AVAH) United States $1.171B 66.67
Pennant (PNTG) United States $1.014B 37.23
Atai Life Sciences (ATAI) Germany $0.327B 0.00
Daxor (DXR) United States $0.036B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.023B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00